STOCK TITAN

Vireo Growth Announces Conference Attendance for September 2026

Vireo Growth will meet investors at a New York life sciences conference, supported by an updated Q2 2026 investor presentation online.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Vireo Growth (VREOD, VREOF) plans to attend the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference on September 9, 2026, in New York City.

Chief Financial Officer Tyson Macdonald will hold one-on-one meetings with investors. The company’s current Q2 2026 investor presentation is available on its investor relations website.

Loading...
Loading translation...

Key Figures

Announcement date: September 2, 2026 Conference date: September 9, 2026 Investor presentation period: Q2 2026
Announcement date
September 2, 2026
Conference attendance announcement
Conference date
September 9, 2026
ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference
Investor presentation period
Q2 2026
Current investor presentation

Historical Context

2 past events · Latest: Jul 02
2 events
  1. Jul 02

    license transaction

    24h Move
    +4.1%

    Expansion into Pennsylvania’s 11th state involved a permit supporting up to six dispensaries.

  2. Jun 18

    dispensary acquisition

    24h Move
    -6.1%

    Completed purchase of a 49% Maryland dispensary interest for $1.55 million.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

otcqx
1 terms
otcqx financial
"Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF)"
OTCQX is the highest tier of the over‑the‑counter (OTC) marketplaces where shares of companies that aren’t listed on major stock exchanges trade. Think of it as a “premium shelf” for OTC stocks: companies must meet stricter financial and disclosure standards, which can mean clearer information, potentially better investor confidence and somewhat easier trading than lower OTC tiers. Investors watch OTCQX listings as a signal of relative transparency and credibility among OTC-traded firms.
View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MINNEAPOLIS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), a leading vertically integrated cannabis company and agricultural markets platform, today announced that it will attend the following conference:

ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference
Chief Financial Officer, Tyson Macdonald, will participate in investor one-on-one meetings.
DATE: September 9, 2026
LOCATION: New York City, NY

Vireo’s current Q2 2026 investor presentation is available on the Company’s investor relations website at: https://investors.vireogrowth.com/events-and-presentations

About Vireo Growth Inc.

Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) is a leading vertically integrated cannabis company building a broad platform across cannabis and adjacent agricultural markets. The Company operates cultivation, manufacturing, retail dispensaries, home delivery, distribution, and agricultural supply businesses across the United States, creating exposure to both cannabis and complementary adjacent markets. With operations in 10 states and more than 170 dispensaries nationwide, Vireo combines disciplined capital allocation, strategic acquisitions, and local market execution to scale its platform and drive long-term shareholder value. The Company is focused on expanding market share and strengthening its portfolio of consumer brands and services, while supporting the customers, employees, shareholders, and communities it serves. For more information about Vireo, visit www.vireogrowth.com.

Contact Information:

Lynn Ricci
Director Investor Relations & Corporate Communications
investor@vireogrowth.com 
(781) 956-7052


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Vireo Growth (VREOD) attend the ATB Cormark life sciences conference?

Vireo Growth is scheduled to attend the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference on September 9, 2026, in New York City, NY. The company’s Chief Financial Officer will participate in one-on-one investor meetings.

Who will represent Vireo Growth (VREOD) at the September 2026 investor conference?

Vireo Growth will be represented by its Chief Financial Officer, Tyson Macdonald, who will participate in one-on-one meetings with investors during the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference.

Where can investors find Vireo Growth’s Q2 2026 presentation mentioned in the conference announcement?

Investors can access Vireo Growth’s current Q2 2026 investor presentation on the company’s investor relations website at https://investors.vireogrowth.com/events-and-presentations, which is highlighted in connection with the September 2026 conference attendance.

What type of investor meetings will Vireo Growth (VREOF) hold at the September 2026 conference?

At the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference, Vireo Growth’s Chief Financial Officer, Tyson Macdonald, will participate in one-on-one meetings with investors, offering direct engagement opportunities with the company’s management.

Keep reading